Research Topic: Medicinal

Identification and biological characterization of pathogen causing sooty blotch of Ardisia crispa (Thunb.) A.DC.

Researchers identified two fungi causing sooty blotch, a serious disease affecting Ardisia crispa, an important Chinese medicinal plant. The disease creates black mold on leaves that reduces the plant’s ability to produce energy through photosynthesis. The study found that extracts from specific medicinal plants can effectively inhibit the growth of these harmful fungi, offering an environmentally friendly alternative to chemical pesticides for protecting these valuable medicinal plants.

Read More »

Genetic regulation of l-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesis

Researchers studied how magic mushrooms (Psilocybe mexicana) control their chemical processes to make psilocybin. They found that when mushrooms start producing psilocybin, they turn on genes that make more of an amino acid called tryptophan, while turning off genes that would break it down. They also discovered and studied an enzyme that helps control tryptophan use. This understanding could help grow these mushrooms with more consistent psilocybin levels for legitimate medical research into treating depression.

Read More »

Past, present and future of antifungals: Advancements in mechanisms of action and resistance

Fungal infections are a growing global health problem, particularly for people with weakened immune systems, causing millions of deaths annually. Current antifungal medications are limited and increasingly ineffective due to drug-resistant fungi. This special issue explores new treatment strategies including novel drugs, combination therapies, and innovative approaches like nanoparticles and antimicrobial peptides to combat these serious infections.

Read More »

The diagnosis of mucormycosis by PCR in patients at risk: a systematic review and meta-analysis

Mucormycosis is a dangerous fungal infection that kills many patients. Traditional tests like fungal culture are slow and often miss infections. This comprehensive study of 30 research papers shows that PCR testing is very effective at detecting this fungus, with different specimen types having different success rates. Blood tests were easiest to perform and worked well for screening high-risk patients, while fluid from the lungs was the most accurate.

Read More »

Saksenaea oblongispora Rhinosinusitis in Advanced HIV: A Rare and Lethal Mucormycosis

A 32-year-old man with advanced HIV developed a severe fungal infection of his sinuses caused by a rare fungus called Saksenaea oblongispora, which typically doesn’t affect people with HIV. The patient presented with severe facial swelling that rapidly worsened, and despite doctors identifying the fungus through biopsies and lab tests, he did not receive antifungal treatment or surgery before his condition became critical. This is the first case of this particular fungal infection documented in sub-Saharan Africa and in HIV patients, highlighting how dangerous this rare infection can be and how challenging it is to diagnose quickly enough to save lives.

Read More »

Biological characterization and in vitro fungicide screening of a new pathogen of basal stem rot of Schisandra chinensis in Jilin Province, China

Researchers discovered that a fungus called Ilyonectria robusta is causing a serious disease in Schisandra chinensis plants grown in northern China. This plant is used to make traditional Chinese medicine. The disease causes the base of the plant stems to rot and die. Scientists tested seven different fungicides (medicines that kill fungi) and found that fluazinam was the most effective at stopping this fungus from growing.

Read More »

Pathogenic mucorales: Deciphering their cell wall polysaccharidome and immunostimulatory potential

Mucormycosis is a serious fungal infection that primarily affects people with weak immune systems and carries high mortality rates. Researchers studied three common mucormycosis-causing fungi to understand how their outer cell layers interact with the human immune system. They found that all three fungi trigger strong inflammatory responses, which may explain why the disease is so damaging. This research helps us better understand how these infections work and could lead to improved treatments or vaccines.

Read More »

Human Gut Microbiome: A Connecting Organ Between Nutrition, Metabolism, and Health

Your gut bacteria function like an extra organ, helping digest food and producing important compounds that affect your whole body. The type of bacteria in your gut depends on diet, delivery method at birth, and antibiotics you’ve taken. Eating more fiber and taking certain probiotics can improve your bacterial balance and help prevent diseases like diabetes, obesity, and heart problems. This suggests that managing your gut microbiome through diet might be just as important as taking traditional medicines for staying healthy.

Read More »

Evaluation of Antifungal Activity Against Candida albicans Isolates From HIV-Positive Patients with Oral Candidiasis in a Major Referral Hospital, West Java, Indonesia

Researchers in West Java, Indonesia studied fungal infections in the mouths of HIV-positive patients to understand which antifungals work best. They found that a common fungal species called Candida albicans was present in all patients tested, though some resistant strains were discovered. The study showed that certain antifungal medications like voriconazole worked better than others, highlighting the importance of testing which specific medications will be effective for each patient rather than guessing.

Read More »

Formulation, characterization, and in vitro antifungal evaluation of liposomal terbinafine prepared by the ethanol injection method

Researchers developed a new way to deliver the antifungal drug terbinafine using tiny fat-based particles called liposomes. These particles are designed to carry the drug more effectively to infected tissues while reducing harmful side effects. The optimized formulation showed promise for treating stubborn fungal infections, especially those affecting the brain, with significantly reduced toxicity compared to the drug alone.

Read More »
Scroll to Top